EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences

Damien Bruyat iD, Nicolas Girard, Pierre Heudel, Nicolas Penel, Marie-Cécile Le Deley, Issaga Diallo, Jean-Marie Boher, Christophe Zemmour, Brice Chanez, Anne Madroszyk, Gwenaelle Gravis, Emilien Billon und 7 weitere

Cancer Communications · 01.01.2026 · 46

DOI: 10.34133/cancomm.0035 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Cancer Communications, online erschienen am 17.06.2026. Verfasst von Damien Bruyat und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
  • Aix-Marseille Université, INSERM U1068, CNRS UMR7258, Centre de Recherche en Cancérologie de Marseille (CRCM), Immunity and Cancer Team, Marseille, France.
  • Department of Medical Oncology, Institut Curie, Paris, France.
  • Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Department of Medical Oncology, Centre Oscar-Lambret, Lille, France.
  • ULR 2694-METRICS (Évaluation des technologies de santé et des pratiques médicales), Centre Hospitalo-Universitaire de Lille, University of Lille, Lille, France.

ORCID-Profile: Damien Bruyat

Zitieren

APA

Bruyat, D., Girard, N., Heudel, P., Penel, N., Le Deley, M. C., Diallo, I., Boher, J. M., Zemmour, C., Chanez, B., Madroszyk, A., Gravis, G., Billon, E., Lisberg, A., Collineau, B., Beaufils, M., Gonçalves, A., Tejeda, M., Chrétien, A. S., & Rochigneux, P. (2026). Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences. Cancer Communications, 46. https://doi.org/10.34133/cancomm.0035

Vancouver

Bruyat D, Girard N, Heudel P, Penel N, Le Deley MC, Diallo I, et al. Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences. Cancer Communications. 2026;46. doi:10.34133/cancomm.0035

BibTeX
@article{Bruyat2026,
  author = {Bruyat, Damien and Girard, Nicolas and Heudel, Pierre and Penel, Nicolas and Le Deley, Marie-Cécile and Diallo, Issaga and Boher, Jean-Marie and Zemmour, Christophe and Chanez, Brice and Madroszyk, Anne and Gravis, Gwenaelle and Billon, Emilien and Lisberg, Aaron and Collineau, Bérénice and Beaufils, Mathilde and Gonçalves, Anthony and Tejeda, Manuel and Chrétien, Anne-Sophie and Rochigneux, Philippe},
  title = {Hyperprogression after Immune Checkpoint Inhibitors: A Cloudy Phenomenon with Real-life Consequences},
  journal = {Cancer Communications},
  year = {2026},
  volume = {46},
  doi = {10.34133/cancomm.0035}
}
Kostenlos starten →